I. Giannopoulou

发表

The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas.

I. Giannopoulou, E. Mylona, A. Kapranou, 2007, Cancer letters.

Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology

K. Kyriacou, L. Nakopoulou, E. Daphnis, 2011, Lupus.

C-erb-B-2 oncoprotein and epidermal growth factor receptor in human hepatocellular carcinoma: an immunohistochemical study.

K. Stefanaki, L. Nakopoulou, I. Giannopoulou, 1994, Histology and histopathology.

M. Karamouzis, A. Papavassiliou, A. Saetta, 2019, American journal of clinical oncology.

Immunohistochemical study of pro-apoptotic factors Bax, Fas and CPP32 in urinary bladder cancer: prognostic implications

A. Lazaris, P. Davaris, I. Giannopoulou, 2002, Urological Research.

Immunohistochemical evaluation of phosphorylated SMAD2/SMAD3 and the co-activator P300 in human glomerulonephritis: correlation with renal injury

D. Koumoundourou, T. Kassimatis, I. Giannopoulou, 2006, Journal of cellular and molecular medicine.

Overexpression of Cyclooxygenase-2 Is Associated with a Favorable Prognostic Phenotype in Breast Carcinoma

I. Papadaki, I. Giannopoulou, E. Mylona, 2005, Pathobiology (Basel).

An immunohistochemical evaluation of phosphorylated Akt at threonine 308 [pAkt(Thr308)] in invasive breast cancer.

I. Giannopoulou, E. Mylona, S. Markaki, 2007, In vivo.

Differential effect of the expression of TGF‐β pathway inhibitors, Smad‐7 and Ski, on invasive breast carcinomas: relation to biologic behavior

I. Giannopoulou, L. Nakopoulou, C. Magkou, 2012, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Effect of Smad pathway activation on podocyte cell cycle regulation: an immunohistochemical evaluation

T. Kassimatis, I. Giannopoulou, L. Nakopoulou, 2014, Renal failure.

High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma.

E. Patsouris, S. Theocharis, G. Tsourouflis, 2017, Neoplasma.

Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2005, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Study of phospho-β-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome

I. Papadaki, N. Kavantzas, I. Giannopoulou, 2006, Modern Pathology.

Study of phospho-beta-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome.

I. Papadaki, N. Kavantzas, I. Giannopoulou, 2006, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions

E. Patsouris, I. Delladetsima, S. Theocharis, 2015, BioMed research international.

Immunohistochemical determination of the extracellular matrix modulation in a rat model of choline‐deprived myocardium: the effects of carnitine

A. Lazaris, I. Giannopoulou, C. Liapi, 2016, Fundamental & clinical pharmacology.

Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression.

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2007, Histology and Histopathology.

An immunohistochemical evaluation of the proteins Wnt1 and glycogen synthase kinase (GSK)‐3β in invasive breast carcinomas

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2013, Histopathology.

The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer

A. Lazaris, I. Giannopoulou, S. Markaki, 2004, Journal of Clinical Pathology.

Effect of BRCA1 immunohistochemical localizations on prognosis of patients with sporadic breast carcinomas.

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2014, Pathology, research and practice.

Evaluation of Numeric Alterations of Chromosomes 1 and 17 by In Situ Hybridization in Invasive Breast Carcinoma With Clinicopathologic Parameters

I. Giannopoulou, A. Keramopoulos, L. Nakopoulou, 2002, Applied immunohistochemistry & molecular morphology : AIMM.

Leucine-rich alpha-2 glycoprotein 1, high mobility group box 1, matrix metalloproteinase 3 and annexin A1 as biomarkers of ulcerative colitis endoscopic and histological activity

M. Gazouli, G. Michalopoulos, A. Lazaris, 2020, European journal of gastroenterology & hepatology.

Immunohistochemical expression of p53 protein and proliferating cell nuclear antigen in hepatocellular carcinoma.

A. Lazaris, L. Nakopoulou, I. Giannopoulou, 1995, Pathology, research and practice.

MMP-3 mRNA and MMP-3 and MMP-1 Proteins in Bladder Cancer: A Comparison With Clinicopathologic Features and Survival

A. Lazaris, C. Constantinides, I. Giannopoulou, 2001, Applied immunohistochemistry & molecular morphology : AIMM.

Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma.

I. Giannopoulou, E. Mylona, S. Markaki, 2007, European Journal of Surgical Oncology.

Expression of lymphatic markers and lymphatic growth factors in psoriasis before and after anti-TNF treatment*

I. Giannopoulou, T. Vergou, P. Alexandrou, 2014, Anais brasileiros de dermatologia.

Evaluation of the vascular endothelial growth factor (VEGF)-C role in urothelial carcinomas of the bladder.

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2006, Anticancer research.

Neutralizing antibody responses in healthcare personnel after three doses of mRNA BNT162b2 vaccine and association with baseline characteristics and past SARS-CoV-2 infection

I. Giannopoulou, G. Dounias, H. Maltezou, 2022, Vaccine.

Peroxisome proliferator-activated receptor gamma expression in urothelial carcinomas of the bladder: association with differentiation, proliferation and clinical outcome.

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2009, European Journal of Surgical Oncology.

Prognostic value of microsatellite instability determined by immunohistochemical staining of hMSH2 and hMSH6 in urothelial carcinoma of the bladder

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2008, Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS).

Clinical significance of histone deacetylase (HDAC)-1, HDAC-2, HDAC-4, and HDAC-6 expression in human malignant and benign thyroid lesions

E. Patsouris, I. Delladetsima, S. Theocharis, 2013, Tumor Biology.

IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers.

A. Vlahou, H. Mischak, A. Lazaris, 2013, Journal of proteome research.

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining.

A. Lazaris, P. Davaris, I. Giannopoulou, 1999, Histopathology.

Extra copies of chromosomes 16 and X in invasive breast carcinomas are related to aggressive phenotype and poor prognosis

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2006, Journal of Clinical Pathology.

Y-box-binding protein 1 (YB1) in breast carcinomas: relation to aggressive tumor phenotype and identification of patients at high risk for relapse.

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2014, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

The clinicopathologic and prognostic significance of CD44+/CD24(-/low) and CD44-/CD24+ tumor cells in invasive breast carcinomas.

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2008, Human pathology.

Study of the topographic distribution of ets-1 protein expression in invasive breast carcinomas in relation to tumor phenotype.

I. Giannopoulou, E. Mylona, S. Markaki, 2006, Cancer Detection and Prevention.

Expression of caspase-3 predicts prognosis in advanced noncardia gastric cancer

A. Lazaris, E. Patsouris, N. Kavantzas, 2014, Medical Oncology.

Effect of the different phosphorylated Smad2 protein localizations on the invasive breast carcinoma phenotype

Eleni Mylona, Ioanna Giannopoulou, I. Giannopoulou, 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Immunohistochemical Study of Bladder Cancer Molecular Subtypes and Their Association with PD-L1 Expression

A. Lazaris, Anastasios Stofas, N. Kavantzas, 2022, Cancers.

Enhanced mRNA expression of tissue inhibitor of metalloproteinase‐1 (TIMP‐1) in breast carcinomas is correlated with adverse prognosis

K. Stefanaki, P. Davaris, I. Giannopoulou, 2002, The Journal of pathology.

Immunohistochemical evaluation of CXCL12-CXCR4 axis and VEGFR3 expression in primary urothelial cancer and its recurrence.

A. Lazaris, E. Patsouris, I. Giannopoulou, 2014, Anticancer research.

Aneuploidy of chromosome 20 in invasive breast cancer correlates with poor outcome.

I. Giannopoulou, L. Nakopoulou, D. Trafalis, 2002, Cancer genetics and cytogenetics.

Expression of the vascular endothelial growth factor receptor-2/Flk-1 in breast carcinomas: correlation with proliferation.

P. Athanassiadou, K. Stefanaki, L. Nakopoulou, 2002, Human pathology.

The prognostic value of vascular endothelial growth factors (VEGFs)-A and -B and their receptor, VEGFR-1, in invasive breast carcinoma.

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2007, Gynecologic oncology.

Cyclin D1 in invasive breast carcinoma: favourable prognostic significance in unselected patients and within subgroups with an aggressive phenotype

I. Giannopoulou, E. Mylona, L. Nakopoulou, 2013, Histopathology.

Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations

P. Korkolopoulou, E. Patsouris, G. Levidou, 2015, PloS one.

Contemporary Molecular Classification of Urinary Bladder Cancer

A. Lazaris, I. Giannopoulou, D. Vlachodimitropoulos, 2021, In Vivo.

Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas

I. Giannopoulou, L. Nakopoulou, C. Magkou, 2008, Breast Cancer Research.

The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases‐1 protein overexpression in breast cancer cells

A. Lazaris, I. Giannopoulou, S. Markaki, 2003, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Prognostic significance of phosphorylated STAT‐1 expression in premenopausal and postmenopausal patients with invasive breast cancer

I. Giannopoulou, L. Nakopoulou, P. Rafailidis, 2012, Histopathology.

Exon 8 amplification of epidermal growth factor receptor (EGFR) in invasive breast carcinomas

I. Giannopoulou, L. Nakopoulou, C. Papadimitriou, 2012, Histopathology.

Prognostic evaluation of oestrogen-regulated protein immunoreactivity in ductal invasive (NOS) breast cancer

A. Lazaris, N. Kavantzas, I. Giannopoulou, 2004, Virchows Archiv.

Corticomedullary mixed adrenal tumor: case report and literature review.

S. Tseleni-Balafouta, G. Kaltsas, I. Giannopoulou, 2009, Endocrine journal.

Matrix metalloproteinase-1 and -3 in breast cancer: correlation with progesterone receptors and other clinicopathologic features.

P. Davaris, I. Giannopoulou, L. Nakopoulou, 1999, Human pathology.

Elevated Hu-Antigen Receptor (HuR) Expression is Associated with Tumor Aggressiveness and Poor Prognosis but not with COX-2 Expression in Invasive Breast Carcinoma Patients

G. Kouraklis, E. Patsouris, S. Theocharis, 2018, Pathology & Oncology Research.

Silencing of Profilin-1 suppresses cell adhesion and tumor growth via predicted alterations in integrin and Ca2+ signaling in T24M-based bladder cancer models

A. Vlahou, H. Mischak, B. Janssen, 2016, Oncotarget.

Expression of tissue inhibitor of matrix metalloproteinases (TIMP)-3 protein in invasive breast carcinoma: Relation to tumor phenotype and clinical outcome

I. Giannopoulou, E. Mylona, S. Markaki, 2006, Breast Cancer Research.

Correlation of Tissue Inhibitor of Metalloproteinase-2 with Proliferative Activity and Patients’ Survival in Breast Cancer

I. Giannopoulou, J. Mavrommatis, A. Keramopoulos, 2002, Modern Pathology.

Microsatellite Instability in Greek Colorectal Carcinoma Patients: Clinicopathological and Molecular Correlations

P. Korkolopoulou, I. Thymara, A. Saetta, 2019, AntiCancer Research.

Abnormal α‐catenin expression in invasive breast cancer correlates with poor patient survival

I. Giannopoulou, A. Keramopoulos, L. Nakopoulou, 2002 .

Abnormal alpha-catenin expression in invasive breast cancer correlates with poor patient survival.

I. Giannopoulou, A. Keramopoulos, L. Nakopoulou, 2002, Histopathology.

PPARγ expression in breast cancer: clinical value and correlation with ERβ

I. Papadaki, I. Giannopoulou, E. Mylona, 2005, Histopathology.

MTOR/4EBP1 signaling and MMR status in colorectal cancer: New correlations and arising perspectives.

Th. Kanellis, A. Lazaris, A. Saetta, 2021, Pathology, research and practice.

Stromelysin-3 Protein Expression in Invasive Breast Cancer: Relation to Proliferation, Cell Survival and Patients’ Outcome

Ioanna Giannopoulou, P. Athanassiadou, I. Giannopoulou, 2002, Modern Pathology.

Transcription Factor Sp1 Expression Is Upregulated in Human Glomerulonephritis: Correlation with pSmad2/3 and p300 Expression and Renal Injury

T. Kassimatis, I. Giannopoulou, L. Nakopoulou, 2010, Renal failure.

Evaluation of E-cadherin/catenin complex in primary and secondary glomerulonephritis.

A. Lazaris, P. Davaris, I. Giannopoulou, 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression.

I. Giannopoulou, E. Mylona, A. Keramopoulos, 2007, Histology and histopathology.